As the Diageo share price falls another 6% in 2025, what should investors do?

The rise of GLP-1 drugs is sending the Diageo share price lower. But Stephen Wright thinks investors should try to avoid getting swept along by the fear.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young Asian woman with head in hands at her desk

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Diageo (LSE:DGE) share price just keeps going lower at the moment. It’s as if someone has told it the story of Jules Verne’s Journey to the Centre of the Earth and the stock thought “sounds like a plan…”.

Created with Highcharts 11.4.3Diageo Plc PriceZoom1M3M6MYTD1Y5Y10YALL14 Jan 202014 Jan 2025Zoom ▾Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '2520212021202220222023202320242024www.fool.co.uk

One of the biggest concerns is Glucagon-like Peptide-1 (GLP-1) drugs that help reverse the effects of diabetes and help combat obesity. And unlike a number of purported innovations – they actually work. 

It turns out though, that GLP-1 drugs aren’t just good for helping people lose weight. They’re also doing a decent job of knocking pounds off the FTSE 100 drinks company’s market cap

Should you invest £1,000 in Meta Platforms right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Meta Platforms made the list?

See the 6 stocks

As a result, Terry Smith has been selling his stake in Diageo, citing concerns about the impact of GLP-1 drugs on the drinks industry as a whole. But is this all just a big overreaction?

How big is the problem?

Gauging the scale of the threat precisely is impossible, but investors can give themselves a rough idea. In 2024, Diageo generated 30% of its sales from the US, where the obesity rate is around 40%. 

GLP-1 drugs are expensive and it looks as though only 50% of the people that might be eligible for them will be able to access them. And there’s a further unknown about how many will stick with it.

The effects wear off if the drugs aren’t taken every day. And with potential side-effects including nausea, sickness, and dizziness, there might well be some who find it difficult to keep taking them.

Lastly, there’s an important issue of demographics. While Diageo doesn’t publish demographic data explicitly, market studies indicate that around two-thirds of its customers are male.

That matters because around men only account for around a third of the people currently using GLP-1 drugs for weight loss. Given all this, I think rumours of this company’s demise are greatly exaggerated.

Risks and uncertainties

Based on these numbers, the impact on Diageo’s top line might be fairly limited. In a pretty optimistic scenario, the impact on revenues could be as low as 1.2% – or 4% of US sales. 

There’s a lot behind these numbers for investors to think about. For example, the firm typically earns strong margins in the US so a 1.2% hit to sales might translate into a bigger reduction in profits.

Another issue is whether people on GLP-1s are those who spend more on Diageo’s products. If they do, then losing that part of the customer base might result in a disproportionate reduction in revenues.

All this is to say that no investor should be dismissing the risk of weight-loss drugs entirely when it comes to Diageo shares. And they should absolutely not be counting on the above numbers as accurate.

I think a precise picture of the threat is impossible to construct at the moment. But I don’t think this justifies the sell-off in the stock, which is why I’m still looking to buy Diageo shares right now.

5 stocks for trying to build wealth after 50

The cost of living crisis shows no signs of slowing… the conflict in the Middle East and Ukraine shows no sign of resolution, while the global economy could be teetering on the brink of recession.

Whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times. Yet despite the stock market’s recent gains, we think many shares still trade at a discount to their true value.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. We believe these stocks could be a great fit for any well-diversified portfolio with the goal of building wealth in your 50’s.

Claim your free copy now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Stephen Wright has positions in Diageo Plc. The Motley Fool UK has recommended Diageo Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s the dividend forecast for Rolls-Royce shares as Trump rocks the markets

Rolls-Royce shares have joined in the volatility over the past week. However, with the direction being largely downwards, the dividend…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Dividend yields of up to 11%! Here are 3 UK passive income stocks to consider

Searching for ways to supercharge your passive income with UK dividend stocks? Here are three that have grabbed our writer's…

Read more »

Young Caucasian woman at the street withdrawing money at the ATM
Investing Articles

£10,000 invested in NatWest shares at the start of 2025 is now worth…

NatWest shares surged into 2025, but things have become a little more complicated in recent weeks. Dr James Fox explores.

Read more »

Investing For Beginners

Why the FTSE 250 could outperform the FTSE 100 for the rest of the year

Jon Smith explains why the FTSE 250 could do better than its big brother when factoring in domestic exposure and…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Tariff fears send the Lloyds share price tumbling, but the dividend yield is climbing

Just when the Lloyds Banking Group share price had been rising steadily, along comes a global upheaval to knock it…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

Here’s how a stock market crash could help an investor retire years early

A stock market crash can be alarming -- but for the well-prepared investor, it can also be an exceptional opportunity…

Read more »

Investing Articles

1 key fact to remember in this stock market correction

This writer takes a look at a FTSE 100 investment trust that is catching his eye after the recent massive…

Read more »

Investing Articles

I was wrong about the Tesla stock price!

Tesla stock's been affected more than most by ‘Liberation Day’. But our writer has other concerns about Elon Musk’s company.

Read more »